DXR
Daxor Corporation
There isn't enough reported data to score DXR yet.
DXR Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate DXR's fundamentals.
DXR PE Valuation
DXR has no meaningful PE right now: it lost money over the past year.
DXR Forward outlook
There aren't enough analyst estimates for DXR to show an outlook.
DXR Earnings Per Share
DXR Quarterly Revenue
DXR Free Cash Flow
DXR Total Shares
DXR Net Leverage
DXR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DXR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.0 | Neutral |
| Stochastic | 9.2 | Oversold |
DXR's weekly RSI is 33 (neutral) and its Stochastic is 9 (oversold).
DXR PE vs Healthcare Sector
DXR has no meaningful PE right now: it lost money over the past year.
DXR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.68 | 13% below |
| 20 week MA | $10.2 | 17% below |
| 50 week MA | $11.0 | 23% below |
| 100 week MA | $10.3 | 18% below |
| 200 week MA | $9.76 | 13% below |
DXR is in a downtrend: it's below all five of its weekly moving averages, and 13% below its 200-week average.
DXR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.80 | $12.9 | +31% |
| 2021 | $12.9 | $11.2 | -13% |
| 2022 | $11.2 | $9.76 | -13% |
| 2023 | $9.76 | $9.60 | -1.6% |
| 2024 | $9.60 | $7.75 | -19% |
| 2025 | $7.75 | $13.9 | +79% |
| 2026 YTD | $13.9 | $8.46 | -39% |
DXR has finished lower in four of the last six years. It's down 39% so far in 2026.